CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells

Blood

Volumn 102, Issue 5, 2003, Pages 1569-1577

  Hanna, Jacob ^b   Wald, Ori ^b   Goldman Wohl, Debra ^b   Prus, Diana ^b   Markel, Gal ^b   Gazit, Roi ^b   Katz, Gil ^b   Haimov Kochman, Ronit ^b   Fujii, Nobutaka ^b   Yagel, Simcha ^b   Peled, Amnon ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 15; LIGAND; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL INVASION; CELL MIGRATION; CULTURE MEDIUM; CYTOKINE PRODUCTION; DECIDUA; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST;

EID: 0042442412     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-02-0517     Document Type: Article

References (53)

1. Bulmer J, Morrison L, Longfellow A, Riston A, Pacem D. Granulate lymphocytes in human endometrium: histochemical and immunhistochemical studies. Hum Reprod. 1991;6:791-798.
2. Loke Y, King A. Human Implantation: Cell Biology and Immunology. Cambridge, United Kingdom: Cambridge University Press; 1995.
3. Norwitz E, Schust D, Fischer SJ. Implantation and the survival of early pregnancy. N Engl J Med. 2001;345:1400-1408.
4. Zhou Y, Fischer SJ, Janatpour M, Genbacey O, Wheelock M, Damsky C. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion. J Clin Invest. 1997;99:2139-2151.
5. King A, Burrows T, Hiby S, et al. Surface expression of HLA-C antigen by human extravillous trophoblasts. Placenta. 2000;21:376-387.
6. Kovats S, Main E, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990;270:630-633.
7. Mandelboim O, Pazmany L, Davis D, et al. Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci U S A. 1997;94:14666-14670.
8. Boyson J, Rybalov U, Koopman L, et al. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci U S A. 2002;99:13741-13746.
9. Croy B, Ashkar A, Minhas K, Greenwood J. Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia? J Soc Gynecol Invest. 2000;7:12-20.
10. Guinmond MJ, Wang B, Croy B. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med. 1998;187:217-223.
11. Ponte M, Cantoni C, Biassoni R, et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells ex. press LIR-1 and CD94-NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A. 1999;96:5674-5679.
12. Verma S, King A, Loke Y. Expression of killer cell inhibitory receptors (KIR) on human uterine NK cells. Eur J Immunol. 1997;27:979-983.
13. Braud V, Jones E, McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequenced derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 1997;27:1164-1169.
14. King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2:656-663.
15. bright natural killer cells via the actions of monocyte inflammatory protein-1alpha. J Exp Med. 2001;193: 1199-1211.
16. Chantakru S, Kuziel W, Maeda N, Croy B. A stud on the density and distribution of uterine natural killer cells at mid pregnancy in mice genetically-ablated for CCR2, CCR5 and the CCR5 receptor ligand, MIP-1 alpha. J Reprod Immunol. 2001;49 33-47.
17. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-127.
18. Proudfoot A. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol. 2002;2: 106-115.
19. Ueno T, Hara K, Willis M, et al. Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus. Immunity 2002;16:205-218.
20. Baekkevold E, Yamanaka T, Palframan R, et al. The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med. 2001;193:1105-1112.
21. Homey B, Alenius H, Muller A, et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med. 2002;8:157-165.
22. + T cells are increased in multiple sclerosis and their ligands MIP-1 alpha and CXCL10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A. 1999;96: 6873-6878.
23. Zou Y, Kottmann A, Kuroda M, Taniuchi I, Littman R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 1998;393:595-599.
24. Berger E. HIV entry and tropism: the chemokine receptor connection. AIDS. 1991;11:3-16.
25. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-56.
26. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoeisis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1998;382:635-638.
27. Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 2002;3:687-694.
28. Markel G, Wolf D, Hanna J, et al. Pivotal role for CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J Clin Invest. 2002;110:943-953.
29. ++ population. Dev Immunol. 1991;1:169-190.
30. Krug A, Uppaluri R, Facchetti F, et al. IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol. 2002;169: 6079-6083.
31. - sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. Blood. 2002;100: 2778-2786.
32. Inngjerdingen M, Bassam D, Maghazachi A. Expression and regulation of chemokine receptors in human natural killer cells. Blood. 2001;97:367-375.
33. Tamamura H, Omagari A, Kanamoto T, et al. Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes. Bioorg Med Chem Lett. 2000;10:2733-2637.
34. McMaster M, Librach C, Zhou Y, et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol. 1995;154: 3771-3778.
35. Chaouat G, Zourbas S, Ostojic S, et al. A brief review of recent data on some cytokine expression at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol. 2002;53:241-256.
36. Vigano P, Gaffuri B, Somigliana E, Infantino M, Vignal M, Blasio A. Interleukin-10 is produced by human uterine natural killer cells but does not affect their production of interferon-gamma. Mol Hum Reprod. 2001;7:971-977.
37. Kitaya K, Yasuda J, Yagi I, Tada Y, Fushiki S, Honjo H. IL-15 expression at human endometrium and decidua. Biol Reprod. 2000;63:683-687.
38. Verma S, Hiby S, Loke Y, King A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod. 2000;63:959-968.
39. Simposon S, Robson SC, Bulmer JN, Barber A, Lyall F. Transforming growth factor beta expression in human placenta and placental bed during early pregnancy. Placenta. 2002;23:44-58.
40. Elsner J, Mack M, Bruhl H, et al. Differential activation of CC chemokine receptors by AOP-RANTES. J Biol Chem. 2000;275:7787-7794.
41. Zimmermann N, Conkright J, Rothenberg M. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem. 1999; 274:12611-12618.
42. Hancock W, Gao W, Csizmadia V, Faia K, Shemmeri N, Luster A. Donor derived IP-10 initiates development of acute allograft rejection. J Exp Med. 2001;193:975-980.
43. Red-Horse K, Drake P, Gunn M, Fisher S. Chemokine ligand and receptor expression in the pregnant uterus. Am J Pathol. 2001;159:2199-2213.
44. Hodge D, Schill W, Wang J, et al. IL-2 and IL-12 alter NK cells responsiveness to IFN-gamma-inducible protein 10 by down regulating CXCR3 expression. J Immunol. 2002;168:6090-6098.
45. Chantakru S, Miller C, Roach L, et al. Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J Immunol. 2002;168:22-28.
46. Mandelboim O, Lieberman N, Lev M, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 2001;409:1055-1060.
47. Whiteside T, Herberman R. The role of natural killer cells in immune surveillance of cancer. Curr Opin Immunol. 1995;7:704-710.
48. Wiltrout R. Regulation and antimetastatic functions of liver-associated natural killer cells. Immunol Rev. 2000;174:63-76.
49. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001; 166:6477-6482.
50. Carson W, Lindemann MJ, Linett ML, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994;180:1395-1403.
51. Polentarutti N, Allavena P, Bianchi G, et al. IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells. J Immunol. 1997;158:2689-2694.
52. Fernandis A, Cherla R, Chernock R, Ganju R. CXCR4/CCR5 down-modulation and chemotaxis are regulated by the proteasome pathway. J Biol Chem. 2002;277:18111-18117.
53. Yoneyama H, Narumi S, Zhang Y, et al. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J Exp Med. 2002;195:1257-1266.